Response to Office Action

PROTHIONE CAPSULES

The Proimmune Company, L.L.C.

Response to Office Action

PTO- 1957
Approved for use through 11/30/2023. OMB 0651-0050
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Response to Office Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90115305
LAW OFFICE ASSIGNED LAW OFFICE 111
MARK SECTION
MARK mark
LITERAL ELEMENT PROTHIONE CAPSULES
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
GOODS AND/OR SERVICES SECTION (current)
INTERNATIONAL CLASS 005
DESCRIPTION
Medicine for improving immune system performance; Supplements for improving immune system performance
FILING BASIS Section 1(b)
GOODS AND/OR SERVICES SECTION (proposed)
INTERNATIONAL CLASS 005
TRACKED TEXT DESCRIPTION
Medicine for improving immune system performance; Pharmaceutical preparations for improving immune system performance; Supplements for improving immune system performance; food, dietary, and nutritional supplements for improving immune system performance
FINAL DESCRIPTION
Pharmaceutical preparations for improving immune system performance; food, dietary, and nutritional supplements for improving immune system performance
        WEBPAGE URL None Provided
        WEBPAGE DATE OF ACCESS None Provided
FILING BASIS Section 1(b)
ADDITIONAL STATEMENTS SECTION
DISCLAIMER No claim is made to the exclusive right to use CAPSULES apart from the mark as shown.
CORRESPONDENCE INFORMATION (current)
NAME JOHN W. MCGLYNN
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmde@ratnerprestia.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER PIM-121US
CORRESPONDENCE INFORMATION (proposed)
NAME John W. McGlynn
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmde@ratnerprestia.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER PIM-121US
SIGNATURE SECTION
RESPONSE SIGNATURE /jwm/
SIGNATORY'S NAME John W. McGlynn
SIGNATORY'S POSITION Attorney for Applicant, DE bar member
DATE SIGNED 09/08/2021
ROLE OF AUTHORIZED SIGNATORY Authorized U.S.-Licensed Attorney
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION SECTION
SUBMIT DATE Wed Sep 08 14:32:21 ET 2021
TEAS STAMP USPTO/ROA-XXX.XXX.XXX.XXX
-20210908143221181256-901
15305-781b440efb980705347
f5cedfc36efa4ff766da7d963
7a4a34a2cd1045a7163745-N/
A-N/A-2021090812425475601
0



PTO- 1957
Approved for use through 11/30/2023. OMB 0651-0050
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Response to Office Action


To the Commissioner for Trademarks:

Application serial no. 90115305 PROTHIONE CAPSULES(Standard Characters, see http://uspto.report/TM/90115305/mark.png) has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following:

Current:
Class 005 for Medicine for improving immune system performance; Supplements for improving immune system performance
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.


Proposed:

Tracked Text Description: Medicine for improving immune system performance; Pharmaceutical preparations for improving immune system performance; Supplements for improving immune system performance; food, dietary, and nutritional supplements for improving immune system performanceClass 005 for Pharmaceutical preparations for improving immune system performance; food, dietary, and nutritional supplements for improving immune system performance
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

Webpage URL: None Provided
Webpage Date of Access: None Provided


ADDITIONAL STATEMENTS
Disclaimer
No claim is made to the exclusive right to use CAPSULES apart from the mark as shown.

Correspondence Information (current):
      JOHN W. MCGLYNN
      PRIMARY EMAIL FOR CORRESPONDENCE: tmde@ratnerprestia.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

The docket/reference number is PIM-121US.
Correspondence Information (proposed):
      John W. McGlynn
      PRIMARY EMAIL FOR CORRESPONDENCE: tmde@ratnerprestia.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

The docket/reference number is PIM-121US.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

SIGNATURE(S)
Response Signature
Signature: /jwm/     Date: 09/08/2021
Signatory's Name: John W. McGlynn
Signatory's Position: Attorney for Applicant, DE bar member
Signature method: Sent to third party for signature

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    JOHN W. MCGLYNN
   RATNERPRESTIA
   
   2200 RENAISSANCE BLVD, SUITE 350
   KING OF PRUSSIA, Pennsylvania 19406
Mailing Address:    John W. McGlynn
   RATNERPRESTIA
   2200 RENAISSANCE BLVD, SUITE 350
   KING OF PRUSSIA, Pennsylvania 19406
        
Serial Number: 90115305
Internet Transmission Date: Wed Sep 08 14:32:21 ET 2021
TEAS Stamp: USPTO/ROA-XXX.XXX.XXX.XXX-20210908143221
181256-90115305-781b440efb980705347f5ced
fc36efa4ff766da7d9637a4a34a2cd1045a71637
45-N/A-N/A-20210908124254756010



uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed